Pharmaceuticals

Premium

Healthcare

15 May, 2024

Bottomline: How PlasmaGen Bio plans to break its streak of revenue stagnancy

Bengaluru-based biopharmaceutical company PlasmaGen Biosciences Pvt. Ltd, backed by venture capital firm Eight Roads Ventures, is poised to break out ......

Premium

Healthcare

30 April, 2024

Exclusive: Advent's healthcare investment platform mulls betting on south Indian API maker

Advent, one of the world’s biggest private equity players, is evaluating an investment in a Chennai-based active pharmaceutical ingredient (API) ......

Premium

Healthcare

25 April, 2024

Searchlight: TCG Lifesciences' topline may take hit on slowing ops in subsidiaries

TCG Lifesciences Pvt. Ltd, a part of The Chatterjee Group, may record a weaker performance for the year ended March ......

Healthcare

16 April, 2024

ChrysCapital invests in Gujarat-based pharma player La Renon Healthcare

Homegrown private equity player ChrysCapital has widened its healthcare portfolio in the country with a $70 million (Rs 585 crore) ......

Premium

Healthcare

10 April, 2024

KKR-controlled JB Chemicals draws interest from PE firms, drugmakers

A clutch of suitors including pharmaceutical companies and bulge-bracket private equity firms have shown interest in picking up a majority ......

Healthcare

14 March, 2024

ChrysCap-backed Eris Life acquires Biocon Biologics' India formulations business

Eris Lifesciences, a Mumbai-based listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, is to acquire ......

Healthcare

01 March, 2024

Advent to merge Cohance, Suven in share-swap deal

Advent International, a global private equity firm, Thursday announced the plan to merge two of its pharmaceutical portfolio companies, Cohance ......

Premium

Healthcare

29 February, 2024

Former Biocon execs' CRAMS firm Anthem Bio eyes pre-IPO funding

Bengaluru-based pharma contract research company Anthem Biosciences Pvt. Ltd, which hit the billion-dollar valuation mark two years ago after private ......

Healthcare

13 February, 2024

ChrysCapital-backed Eris Life acquires controlling stake in Swiss Parenterals for $77 mn

Listed pharmaceuticals player Eris Lifesciences Ltd has acquired 51% stake in sterile injectables company Swiss Parenterals for Rs 637.5 crore ......

Healthcare

12 February, 2024

Manipal Hospitals backer Novo Holdings to invest $35 bn over next six years

Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, plans to invest about $35 billion by 2030, CEO ......